BACKGROUND: Brain-derived neurotrophic factor (BDNF) is putatively involved in the pathophysiology of depression. This study examined associations between BDNF genotype at the Val66Met locus, depression symptoms, and serum BDNF levels. METHODS: Twenty-eight subjects in the primary study (25 female, 3 male) completed diagnostic interviews, self-report questionnaires, and provided blood samples for serum BDNF quantification and buccal cell samples for genotyping. Data from a second sample of 189 subjects (94 female, 95 male) were also analyzed. RESULTS: The Val/Val genotype was associated with higher scores on the Cognitive-Affective factor of the Beck Depression Inventory-II (BDI-II) in the primary sample. No evidence was found for association between genotype and serum BDNF in this sample. Consistent with the primary study, Val/Val genotype was associated with higher total BDI-II scores, Cognitive-Affective factor scores, and Somatic-Vegetative factor scores, in the second sample. Serum BDNF measures were not available for the second sample. LIMITATIONS: The mechanism through which BDNF genotype translates into (putative) differences in depression symptoms is not known. CONCLUSIONS: In contrast to case-control association studies, we demonstrate two changes in the operationalization of the phenotype. Additionally, we found an association between Val/Val genotype and higher levels of depression symptoms. This result is distinct from an association between BDNF genotype and diagnosis of depression, and it may help to clarify our understanding of genetic liability to depression, which will ultimately lead to more nuanced and effective treatment strategies.
BACKGROUND:Brain-derived neurotrophic factor (BDNF) is putatively involved in the pathophysiology of depression. This study examined associations between BDNF genotype at the Val66Met locus, depression symptoms, and serum BDNF levels. METHODS: Twenty-eight subjects in the primary study (25 female, 3 male) completed diagnostic interviews, self-report questionnaires, and provided blood samples for serum BDNF quantification and buccal cell samples for genotyping. Data from a second sample of 189 subjects (94 female, 95 male) were also analyzed. RESULTS: The Val/Val genotype was associated with higher scores on the Cognitive-Affective factor of the Beck Depression Inventory-II (BDI-II) in the primary sample. No evidence was found for association between genotype and serum BDNF in this sample. Consistent with the primary study, Val/Val genotype was associated with higher total BDI-II scores, Cognitive-Affective factor scores, and Somatic-Vegetative factor scores, in the second sample. Serum BDNF measures were not available for the second sample. LIMITATIONS: The mechanism through which BDNF genotype translates into (putative) differences in depression symptoms is not known. CONCLUSIONS: In contrast to case-control association studies, we demonstrate two changes in the operationalization of the phenotype. Additionally, we found an association between Val/Val genotype and higher levels of depression symptoms. This result is distinct from an association between BDNF genotype and diagnosis of depression, and it may help to clarify our understanding of genetic liability to depression, which will ultimately lead to more nuanced and effective treatment strategies.
Authors: Srijan Sen; Randolph M Nesse; Scott F Stoltenberg; Sheng Li; Lillian Gleiberman; Aravinda Chakravarti; Alan B Weder; Margit Burmeister Journal: Neuropsychopharmacology Date: 2002-08-29 Impact factor: 7.853
Authors: Vaishnav Krishnan; Ming-Hu Han; Danielle L Graham; Olivier Berton; William Renthal; Scott J Russo; Quincey Laplant; Ami Graham; Michael Lutter; Diane C Lagace; Subroto Ghose; Robin Reister; Paul Tannous; Thomas A Green; Rachael L Neve; Sumana Chakravarty; Arvind Kumar; Amelia J Eisch; David W Self; Francis S Lee; Carol A Tamminga; Donald C Cooper; Howard K Gershenfeld; Eric J Nestler Journal: Cell Date: 2007-10-19 Impact factor: 41.582
Authors: Kent E Hutchison; David L Allen; Francesca M Filbey; Christopher Jepson; Caryn Lerman; Neal L Benowitz; Jerry Stitzel; Angela Bryan; John McGeary; Heather M Haughey Journal: Arch Gen Psychiatry Date: 2007-09
Authors: Rong-Jian Liu; Francis S Lee; Xiao-Yuan Li; Francis Bambico; Ronald S Duman; George K Aghajanian Journal: Biol Psychiatry Date: 2011-10-29 Impact factor: 13.382
Authors: Antonio Terracciano; Maria Grazia Piras; Monia Lobina; Antonella Mulas; Osorio Meirelles; Angelina R Sutin; Wayne Chan; Serena Sanna; Manuela Uda; Laura Crisponi; David Schlessinger Journal: World J Biol Psychiatry Date: 2011-11-02 Impact factor: 4.132
Authors: Rong Jiang; Beverly H Brummett; Michael A Babyak; Ilene C Siegler; Redford B Williams Journal: J Psychiatr Res Date: 2012-11-08 Impact factor: 4.791